% This file was created with Citavi 5.7.1.0

@book{Brandt.2012,
 abstract = {Das gro{\ss}e Referenz- und Facharztbuch zur klinischen Neurologie liegt hiermit unter der Federf{\"u}hrung der international renommierten Herausgeber und der Mitarbeit von {\"u}ber 140 Fachexperten als eine vollst{\"a}ndig {\"u}berarbeitete und erweiterte Neuauflage vor. Durch die thematische Neuausrichtung einzelner Beitr{\"a}ge, z. B. zur transienten globalen Amnesie oder zu Tropenkrankheiten, und acht zus{\"a}tzliche Kapitel, n{\"a}mlich zu Antik{\"o}rper-assoziierten Enzephalopathien, mitochondrialen Erkrankungen, atypischem Gesichtsschmerz, craniomandibul{\"a}rer Dysfunktion, Hypophysentumoren, Tic/Tourette und ADS, Apraxie sowie ethischen und rechtlichen Aspekten in der Neurologie, hat die 6. Auflage viel Neues zu bieten. In bew{\"a}hrter Form werden systematisch die aktuellen Erkenntnisse zum Stand von Klinik, Therapie und Verlauf neurologischer Erkrankungen zusammengefasst und f{\"u}r die pragmatische Anwendung gewichtet.  Prof. Dr. med. Dr. h.c. Thomas Brandt, ehem. Direktor der Universit{\"a}tsklinik und Poliklinik f{\"u}r Neurologie der Ludwig-Maximilians-Universit{\"a}t M{\"u}nchen (Klinikum Gro{\ss}hadern), ist Leiter des Deutschen Schwindelzentrums und Inhaber der ersten Hertie-Senior-Forschungsprofessur Neurowissenschaften.    Prof. Dr. med. Hans Christoph Diener, Vorsitzender der Kommission Leitlinien der DGN, ist Direktor der Universit{\"a}tsklinik f{\"u}r Neurologie, des Westdeutschen Kopfschmerzzentrums und des Schwindelzentrums Essen.    Prof. Dr. med. Christian Gerloff ist Direktor der Klinik und Poliklinik f{\"u}r Neurologie, {\"a}rztlicher Leiter des Kopf- und Neurozentrums am Universit{\"a}tsklinikum Hamburg-Eppendorf und Sprecher der Hamburger Arbeitsgemeinschaft Schlaganfall.



Long description: Mit teilweise neuer inhaltlicher Struktur, neuer thematischer Ausrichtung einzelner Beitr{\"a}ge und neuen Kapiteln, z. B. zu Apraxie, atypischem Gesichtsschmerz, Tic, Tourette und ADS, Mitochondrialen Erkrankungen, Hypophysentumoren sowie zu ethischen und rechtlichen Aspekten in der Neurologie, hat diese Auflage viel Neues zu bieten. Das etablierte Werk kn{\"u}pft an den Erfolg der Vorauflagen an und wird f{\"u}r die allt{\"a}gliche Arbeit von Fach- und Allgemeinmedizinern in Klinik und Praxis sowie f{\"u}r eine erfolgreiche Aus-, Fort- und Weiterbildung unersetzlich sein.},
 year = {2012},
 title = {Therapie und Verlauf neurologischer Erkrankungen},
 url = {http://gbv.eblib.com/patron/FullRecord.aspx?p=1582175},
 address = {s.l.},
 edition = {6., vollst. {\"u}berarb. und erw. Aufl.},
 publisher = {{Kohlhammer Verlag}},
 isbn = {9783170216747},
 editor = {Brandt, Thomas and Diener, Hans-Christoph and Gerloff, Christian}
}


@article{Brodie.2010,
 abstract = {Seizure: European Journal of Epilepsy, 19 (2010) 650-655. 10.1016/j.seizure.2010.10.027},
 author = {Brodie, Martin J.},
 year = {2010},
 title = {Antiepileptic drug therapy the story so far},
 keywords = {Animals;Anticonvulsants/history/pharmacology;Antiepileptic drugs;Epilepsy;Epilepsy/drug therapy;History, 19th Century;History, 20th Century;History, 21st Century;Humans;Mechanism of action;Pharmacoresistance;Prognosis},
 urldate = {18.06.2018},
 pages = {650--655},
 volume = {19},
 number = {10},
 journal = {Seizure},
 doi = {10.1016/j.seizure.2010.10.027}
}


@misc{DGN.2017,
 author = {Elger, Christian and Berkenfeld, Ralf},
 date = {2017},
 title = {S1 Leitlinie: Erster epileptischer Anfall und Epilepsien im Erwachsenenalter},
 url = {https://www.awmf.org/uploads/tx_szleitlinien/030-041l_S1_Erster-epileptischer-Anfall_Epilespien_2018-05.pdf},
 urldate = {19.06.2018},
 number = {01},
 editor = {{Kommission Leitlinien der Gesellschaft f{\"u}r Neurologie}},
 institution = {{AWMF online}},
 doi = {10.1055/s-0043-124999}
}


@article{Eadie.2012,
 abstract = {On 12 May 1857, Edward Sieveking read a paper on epilepsy to the Royal Medical and Chirurgical Society in London. During the discussion that followed Sir Charles Locock, obstetrician to Queen Victoria, was reported to have commented that during the past 14 months he had used potassium bromide to successfully stop epileptic seizures in all but one of 14 or 15 women with 'hysterical' or catamenial epilepsy. This report of Locock's comment has generally given him credit for introducing the first reasonably effective antiepileptic drug into medical practice. However examination of the original reports raises questions as to how soundly based the accounts of Locock's comments were. Subsequently, others using the drug to treat epilepsy failed to obtain the degree of benefit that the reports of Locock's comments would have led them to expect. The drug might not have come into more widespread use as a result, had not Samuel Wilks provided good, independent evidence for the drug's antiepileptic efficacy in 1861.},
 author = {Eadie, M. J.},
 year = {2012},
 title = {Sir Charles Locock and potassium bromide},
 keywords = {Anticonvulsants/history/therapeutic use;Bromides/history/therapeutic use;Epilepsy/drug therapy/history;Female;History, 19th Century;Humans;Obstetrics/history;Potassium Compounds/history/therapeutic use;United Kingdom},
 urldate = {18.06.2018},
 pages = {274--279},
 volume = {42},
 number = {3},
 journal = {The journal of the Royal College of Physicians of Edinburgh},
 doi = {10.4997/JRCPE.2012.317}
}


@article{Ernst.1988,
 abstract = {Thirty-six children with epilepsy resistant to conventional treatment were treated with bromides in addition to the current therapy. Six out of 19 cases with prevailingly or exclusively generalized tonic-clonic seizures became seizure-free and in 9 cases a reduction in seizure frequency of more than 50{\%} was achieved. Freedom from seizures could not be obtained in 13 cases, who had frequent minor seizures in addition to generalized tonic-clonic seizures. In some, minor seizures were even activated. Tonic and focal seizures showed no response. Side effects were observed in one-third of the cases (acne, loss of appetite, loss of weight, fatigue) but in no case they did become intolerable. Fifty to 80 mg potassium bromide per kg body weight seems to be an effective daily dose range. There is a preferential indication of bromides for patients suffering from early onset epilepsy with generalized tonic-clonic seizures and/or alternating hemigrand mal, for whom other treatment is ineffective. This disorder is characterized by a high familial incidence of epileptic seizures, onset between 6 months and 3 years of age, normal development until the onset of seizures, generalized tonicclonic seizures and often alternating hemi-grand mal, seizure precipitation by fever, and occasional combination with or transition to myoclonic-astatic and/'or myoclonic seizures. EEG is often normal or shows slight slowing in the initial phase; later it shows theta rhythms and generalized spikes and waves. Especially, if the onset is during the first year of life, the course of the epilepsy is often unfavourable. Key words: Epilepsy, generalized tonic-clonic seizures, therapy, bromides.},
 author = {Ernst, Jan-Peter and Doose, Hermann and Baier, Wolfgang K.},
 year = {1988},
 title = {Bromides were effective in intractable epilepsy with generalized tonic-clonic seizures and onset in early childhood},
 pages = {385--388},
 volume = {10},
 number = {6},
 issn = {0387-7604},
 journal = {Brain and Development},
 doi = {10.1016/S0387-7604(88)80098-6}
}


@article{Fisher.2005,
 abstract = {Summary:  The International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE) have come to consensus definitions for the terms epileptic seizure and epilepsy. An epileptic seizure is a transient occurrence of signs and/or symptoms due to abnormal excessive or synchronous neuronal activity in the brain. Epilepsy is a disorder of the brain characterized by an enduring predisposition to generate epileptic seizures and by the neurobiologic, cognitive, psychological, and social consequences of this condition. The definition of epilepsy requires the occurrence of at least one epileptic seizure.},
 author = {Fisher, Robert S. and {van Boas}, Walter Emde and Blume, Warren and Elger, Christian and Genton, Pierre and Lee, Phillip and Engel, Jerome},
 year = {2005},
 title = {Epileptic Seizures and Epilepsy: Definitions Proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)},
 pages = {470--472},
 volume = {46},
 number = {4},
 issn = {1528-1167},
 journal = {Epilepsia},
 doi = {10.1111/j.0013-9580.2005.66104.x}
}


@article{Hauptmann.1912,
 author = {Hauptmann, A.},
 year = {1912},
 title = {Luminal bei Epilepsie},
 pages = {1907--1909},
 number = {59},
 journal = {Munch Med Wochenschr}
}


@article{Merritt.1938,
 author = {Merritt, H. Houston and Putnam, Tracy J.},
 year = {1938},
 title = {Sodium diphenyl hydantoinate in the treatment of convulsive disorders},
 pages = {1068--1073},
 volume = {111},
 number = {12},
 issn = {0002-9955},
 journal = {Journal of the American Medical Association}
}


@article{OConnor.1857,
 author = {O'Connor},
 year = {1857},
 title = {CASES OF EPILEPSY, ASSOCIATED WITH AMENORRHOElA AND VICARIOUS MENSTRUATION, SUCCESSFULLY TREATED WITH THE IODIDE OF POTASSIUM.},
 pages = {525},
 volume = {69},
 number = {1760},
 issn = {01406736},
 journal = {The Lancet},
 doi = {10.1016/S0140-6736(02)57564-4}
}


@article{Sieveking.1857,
 author = {Sieveking, Edward H.},
 year = {1857},
 title = {ANALYSIS OF FIFTY-TWO CASES OF EPILEPSY OBSERVED BY~THE~AUTHOR},
 urldate = {18.06.2018},
 pages = {157--166},
 number = {40},
 journal = {Medico-Chirurgical Transactions.}
}


@book{ToddRobertBentley18091860.,
 author = {Todd, Robert Bentley},
 year = {1855},
 title = {Clinical lectures on paralysis, disease of the brain, and other affections of the nervous system},
 keywords = {http://archive.org/details/66320300R.nlm.nih.gov},
 address = {Philadelphia},
 urldate = {18.06.2018},
 publisher = {{Lindsay {\&} Blakiston}}
}


@article{Yasiry.2012,
 abstract = {Epilepsia 2012.53:26-39},
 author = {Yasiry, Zeid and Shorvon, Simon D.},
 year = {2012},
 title = {How phenobarbital revolutionized epilepsy therapy: The story of phenobarbital therapy in epilepsy in the last 100 years},
 keywords = {Adult;Anticonvulsants/adverse effects/history/pharmacokinetics/therapeutic use;Clinical Trials as Topic/history;Drug Costs/history;Epilepsy/drug therapy/history;Europe;Germany;History, 19th Century;History, 20th Century;Humans;Phenobarbital/adverse effects/history/pharmacokinetics/therapeutic use;Philately;United States},
 urldate = {19.06.2018},
 pages = {26--39},
 volume = {53 Suppl 8},
 issn = {1528-1167},
 journal = {Epilepsia},
 doi = {10.1111/epi.12026}
}


